Showing results (391-400 of 461) with videos related to

Sort By:
Pageof 47
Diabetes Care|October 4, 2013
External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equationsChristian A Bannister, Chris D Poole, Sara Jenkins-Jones, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1994
Spatial and temporal correlation between leukocyte behavior and cell injury in postischemic rat skeletal muscle microcirculationM Suematsu, F A DeLano, D Poole, et al.
Diabetes Care|January 24, 2012
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survivalCraig J Currie, Chris D Poole, Sara Jenkins-Jones, et al.
Rheumatology (Oxford, England)|October 22, 2013
Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational dataChristopher Ll Morgan, Paul Emery, Duncan Porter, et al.
Virology Journal|June 11, 2011
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typingDaniel N Clark, Brian D Poole, Daniel V Hammond, et al.
British Journal of Plastic Surgery|January 5, 2000
A quantitative analysis of the effect of insulin-like growth factor-1 infusion during mandibular distraction osteogenesis in rabbitsK J Stewart, B Weyand, R J van't Hof, et al.
Epidemiology and Infection|June 30, 2015
The role of the intensive care unit in real-time surveillance of emerging pandemics: the Italian GiViTI experienceG Bertolini, G Nattino, M Langer, et al.
Arthritis and Rheumatism|February 28, 2009
Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosusBrian D Poole, Rebecca I Schneider, Joel M Guthridge, et al.
Plos One|January 22, 2021
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosisDeborah K Johnson, Kaylia M Reynolds, Brian D Poole, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1996
Reflux symptom relief with omeprazole in patients without unequivocal oesophagitisC M Bate, S M Griffin, P W Keeling, et al.
Pageof 47